WHA74: KEI’s statement on the global strategy and plan of action on public health, innovation, and intellectual property

At the World Health Organization’s 74th World Health Assembly, Knowledge Ecology International delivered the following remarks on WHO’s global strategy and plan of action on public health, innovation, and intellectual property on Saturday, 29 May 2021. Non-state actors are limited… Continue Reading

People’s Vaccine Alliance Letter to Prime Minister Trudeau Urgently Requesting the Amendment of Schedule 1

On May 18th, the People’s Vaccine Alliance sent Justin Trudeau, Prime Minister of Canada, a letter urgently requesting that vaccines, therapeutics and diagnostics for COVID-19 be added to Schedule 1 of the Patent Act. Below is the text of the PVA… Continue Reading

41 Canadian Experts Request Amendment to Schedule 1 of the Patent Act to include COVID-19 vaccines

On April 27th, a letter signed by 41 Canadian experts was sent to the Prime Minister of Canada, the Minister of Innovation, Science & Industry, and the Minister of Health. The letter requests the amendment of Schedule 1 of the… Continue Reading

COVID-related Needle and Syringe Contracts

United States of America Becton Dickinson and Company- needle production. DoD/ASPR/BARDA-Becton Dickinson Contract W911SR2030001. July 1, 2020. (Version obtained via FOIA lawsuit in March 2021) DoD/ASPR/BARDA-Becton Dickinson Contract W911SR2030001. July 1, 2020. (Version obtained via HHS Reading Room in October… Continue Reading

KEI Statement at WTO COVID-19 Vaccine Equity Event

On Wednesday April 14, 2021, the World Trade Organization hosted an event titled “COVID-19 and Vaccine Equity: What can the WTO contribute?” which featured three sessions concerning vaccine distribution, manufacturing, and looking forward at how the system could better address… Continue Reading

Fissures on intellectual property, C-TAP and transparency emerge in WHO local production negotiations

On 4 December 2020, Ethiopia submitted a Zero Draft resolution to the World Health Organization (WHO) on Strengthening Local Production of Medicines and Other Health Technologies to Improve Access – WHO Resolution on Strengthening Local Production of Medicines and Other… Continue Reading

License to NIH Spike Protein Technology Needed in COVID-19 Vaccines Demonstrates “Available to the Public on Reasonable Terms” Requirement

A March 21, 2021 New York Times article on vaccine access discusses how a technology invented and owned by the National Institutes of Health (NIH) is necessary to make several COVID-19 vaccines. The invention mentioned by the Times, titled Prefusion… Continue Reading

Luis Gil Abinader NIST comments on the definition of Subject Invention, 26 March 2021

PDF version here:LGA-NIST-Subject-Invention-definition-26March2021 More on the NIST proposed changes to the Bayh-Dole Regulations. https://www.keionline.org/35432 Comments of Luis Gil Abinader of Knowledge Ecology International on the redefinition of “Subject Invention” to Narrow the Inventions to Which Government Rights Attach (Modify 37… Continue Reading